US generics supplier Amneal has not ruled out playing in international markets, even though it has just sold off its operations in the UK and Germany. However, any move abroad would have to come through a transaction that immediately gave the firm critical mass, CEO Rob Stewart told investors.
At the end of first quarter, Amneal sold its Creo Pharma subsidiary in the UK to Zentiva’s AI Sirona vehicle...





